Flt 4 kinase inhibitors (Sareum)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameFlt 4 kinase inhibitors (Sareum)
Drug Alias NameVEGFR-3 kinase inhibitors (Sareum)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVascular endothelial growth factor receptor 3 antagonists
TargetsVascular endothelial growth factor receptor 3
Therapy Area/IndicationsNeoplasm MetastasisNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusSuspended
Highest Status in ChinaN/A
Originator CompaniesSareum Holdings plc
China Registration ClassN/A

Develop Information

Active CompaniesSareum Holdings plc
Inactive CompaniesN/A
Active IndicationsNeoplasm Metastasis
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A